Tocopheryl succinate - Versatile functions due to its unique physicochemical properties

Journal of Clinical Biochemistry and Nutrition

Volumn 35, Issue 1, 2004, Pages 29-34

  Kogure, Kentaro ^a   Fukuzawa, Kenji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Tocopheryl succinate; Anti cancer; Apoptosis; Melanoma; Tumor

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ANTINEOPLASTIC AGENT; PROTEIN KINASE C;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BILAYER MEMBRANE; CANCER INHIBITION; CYTOPATHOGENIC EFFECT; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; LIPID MEMBRANE; MOLECULAR MECHANICS; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SIGNAL TRANSDUCTION;

EID: 10044282828     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.35.29     Document Type: Review

References (56)

1. Badamchian, M., Spangelo, B.L., Bao, Y., Hagiwara, Y., Hagiwara, H., Ueyama, H., and Goldstein, A.L.: Isolation of a vitamin E analog from a green barley leaf extract that stimulates release of prolactin and growth hormone from rat anterior pituitary cells in vitro. J. Nutr. Biochem., 5, 145-150, 1994.
2. Suzuki, Y.J. and Packer, L.: Inhibition of NF-κB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun., 193, 277-283, 1993.
3. Suzuki, Y.J. and Packer, L.: Inhibition of NF-κB DNA binding activity by α-tocopheryl succinate. Biochem. Mol. Biol. Int., 31, 693-700, 1993.
4. Nakamura, T., Goto, M., Matsumoto, A., and Tanaka, L: Inhibition of NF-κB transcriptional activity by α-tocopheryl succinate. BioFactors, 31, 21-30, 1998.
5. Dalen, H. and Neuzil, J.: α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation. Br. J. Cancer, 88, 153-158, 2003.
6. Kogure, K., Morita, M., Hama, S., Nakashima, S., Tokumura, A., and Fukuzawa, K.: Enhancement by α-tocopheryl hemisuccinate of nitric oxide production induced by lypopolysaccharide and interferon-γ through up-regulation of protein kinase C in rat vascular smooth muscle cells. Eur. J. Biochem., 269, 2367-2372, 2002.
7. Fariss, M.W., Fortuna, M.B., Everett, C.K., Smith, J.D., Trent, D.F., and Djuric, Z.: The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res., 54, 3346-3351, 1994.
8. Turley, J.M., Funakoshi, S., Ruscetti, F.W., Kasper, J., Murphy, W.J., Longo, D.L., and Birchenall-Roberts, M.C.: Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor-β. Cell Growth Differ., 6, 655-663, 1995.
9. Kogure, K., Morita, M., Nakashima, S., Hama, S., Tokumura, A., and Fukuzawa, K.: Superoxide is responsible for apoptosis in rat vascular smooth muscle cells induced by α-tocopheryl succinate. Biochim. Biophys. Acta, 1528, 25-30, 2001.
10. Kogure, K., Hama, S., Manabe, S., Tokumura, A., and Fukuzawa, K.: High cytotoxicity of α-tocopheryl hemisuccinate to cancer cells is due to failure of their antioxidative defense systems. Cancer Lett., 186, 151-156, 2002.
11. Kogure, K., Hama, S., Kisaki, M., Takemasa, H., Tokumura, A., Suzuki, I., and Fukuzawa, K.: Structural characteristic of terminal dicarboxylic moiety required for apoptogenic activity of α-Tocopheryl esters. Biochim. Biophys. Acta, 1672, 93-99, 2004.
12. Neuzil, J., Weber, T., Terman, A., Weber, C., and Brunk, U.T.: Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic role. Redox Rep., 6, 143-151, 2001.
13. Neuzil, J., Schröder, A., Hundelshausen, P., Zernecke, A., Weber, T., Gellert, N., and Weber, C.: Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. Biochemistry, 40, 4686-4692, 2001.
14. Neuzil, J., Weber, T., Schröder, A., Lu, M., Ostermann, G., Gellert, N., Mayne, G.G., Olejnicka, B., Nègre-salvayre, A., Sticha, M., Coffey, R.J., and Weber, C.: Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements. FASEB J., 15, 403-415, 2001.
15. Neuzil, J., Weber, T., Gellert, N., and Weber, C.: Selective cancer cell killing by α-tocopheryl succinate. Br. J. Cancer, 84, 87-89, 2001.
16. Qian, M., Kralova, J., Yu, W., Bose, H.R. Jr., Dvorak, M., Sanders, B.G., and Kline, K.: c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene, 15, 223-230, 1997.
17. Turley, J.M., Fu, T., Ruscetti, F.W., Mikovits, J.A., Bertolette, D.C. III, and Birchenall-Roberts, M.C.: Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res., 57, 881-890, 1997.
18. Yamamoto, S., Tamai, H., Ishisaka, R., Kanno, T., Arita, K., Kobuchi, H., and Utsumi, K.: Mechanism of α-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells. Free Radic. Res., 33, 407-418, 2000.
19. You, H., Yu, W., Sanders, B.G., and Kline, K.: RRR-α-Tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ., 12, 471-480, 2001.
20. Yu, W., Heim, K., Qian, M., Simmons-Menchaca, M., Sanders, B.G., and Kline, K.: Evidence for role of transforming growth factor-β in RRR-α-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr. Cancer, 27, 267-278, 1997.
21. Yu, W., Israel, K., Liao, Q.Y., Aldaz, C.M., Sanders, B.G., and Kline, K.: Vitamin E succinate (VES) induced Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res., 59, 953-961, 1999.
22. 2-terminal kinase but not p38 mitogen-activated protein kinase is required for RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res., 61, 6569-6576, 2001.
23. Lai, M.-Z., Düzgünes, N., and Szoka, F.C.: Effects of replacement of the hydroxyl group of cholesterol and tocopherol on the thermotropic behavior of phospholipids membranes. Biochemistry, 24, 1646-1653, 1985.
24. Boni, L.T., Perkins, W.R., Minchey, S.R., Bolcsak, L.E., Gruner, S.M., Cullis, P.R., Hope, M.J., and Janoff, A.S.: Polymorphic phase behavior of alpha-tocopherol hemisuccinate. Chem. Phys. Lipids, 54, 193-203, 1990.
25. Massey, J.B.: Interfacial properties of phosphatidylcholine bilayers containing vitamin E derivatives. Chem. Phys. Lipids, 109, 157-174, 2001.
26. Fukuzawa, K., Ikeno, H., Tokumura, A., and Tsukatani, H.: Effect of α-tocopherol incorporation on glucose permeability and phase transition of lecithin liposomes. Chem. Phys. Lipids, 23, 13-22, 1979.
27. Fukuzawa, K., Chida, H., and Suzuki, A.: Fluorescence depolarization studies of phase trasition and fluidity in lecithin liposomes containing α-tocopherol. J. Nutr. Sci. Vitaminol., 26, 427-434, 1980.
28. Jizomoto, H., Kanaoka, E., and Hirano, K.: pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate. Biochim. Biophys. Acta, 1213, 343-348, 1984.
29. Barnett, K.T., Fokum, F.D., and Malafa, M.P.: Vitamin E succinate inhibits colon cancer liver metastases. J. Surg. Res., 106, 292-298, 2002.
30. Malafa, M.P. and Neitzel, L.T.: Vitamin E succinate promotes breast cancer tumor dormancy. J. Surg. Res., 93, 163-170, 2000.
31. Malafa, M.P., Fokum, F.D., Mowlavi, A., Abusief, M., and King, M.: Vitamin E inhibits melanoma growth in mice. Surgery, 131, 85-91, 2002.
32. Malafa, M.P., Fokum, F.D., Smith, L., and Louis, A.: Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate. Ann. Surg. Ongol., 9, 1023-1032, 2002.
33. Weber, T., Lu, M., Andera, L., Lahm, H., Gellert, N., Fariss, M.W., Korinek, V., Sattler, W., Ucker, D.S., Terman, A., Schröder, A., Erl, W., Brunk, U.T., Coffey, R.J., Weber, C., and Neuzil, J.: Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin. Cancer Res., 8, 863-869, 2002.
34. Allen, T.M.: Liposomes: Opportunities in drug delivery. Drugs, 54, 8-14, 1997.
35. Kogure, K., Manabe, S., Hama, S., Tokumura, A., and Fukuzawa, K.: Potentiation of anti-cancer effect by intra venous administration of vesiculated α-tocopheryl hemisuccinate on mouse melanoma in vivo. Cancer Lett., 192, 19-24, 2003.
36. Birringer, M., EyTina, J.H., Salvatore, B.A., and Neuzil, J.: Vitamin E analogues as inducers of apoptosis: structure-function relation. Br. J. Cancer, 88, 1948-1955, 2003.
37. Yu, W., Sanders, B.G., and Kline, K.: RRR-α-Tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr. Cancer, 27, 92-101, 1997.
38. Zhao, Y., Wu, K., Xia, W., Shan, Y.-J., Wu, L.-J., and Yu, W.-P.: The effects of vitamin E succinate on the expression of c-Jun gene and protein in human gastric cancer SGC-7901 cells. World J. Gastroenterol., 8, 782-786, 2002.
39. Israel, K., Yu, W., Sanders, B.G., and Kline, K.: Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr. Cancer, 36, 90-100, 2000.
40. Wu, K., Li, Y., Zhao, Y., Shan, Y.-J., Xia, W., Yu, W.-P., and Zhao, L.: Roles of Fas signaling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells. World J. Gastroenterol., 8, 982-986, 2002.
41. Neuzil, J., Zhao, M., Ostermann, G., Sticha, M., Gellert, N., Weber, C., Eaton, J.W., and Brunk, U.T.: α-Tocopheryl succinate, an agent with in vito anti-tumor activity, induces apoptosis by causing lysosomal instability. Biochem. J., 362, 709-715, 2002.
42. Bang, O.-S., Park, J.-H., and Kang, S.-S.: Activation of PKC but not of ERK is required for vitamin E-succinate induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun., 288, 789-797, 2001.
43. Kogure, K., Hama, S., Goto, S., Munakata, T., Tokumura, A., and Fukuzawa, K.: α-Tocopheryl succinate activates protein kinase C in cellular and cell-free systems. J. Nutr. Sci. Vitaminol., 49, 310-314, 2003.
44. You, H., Yu, W., Munoz-Medelline, D., Brown, P.H., Sanders, B.G., and Kline, K.: Role of extracellular signal-regulated kinase pathway in RRR-α-tocopheryl succinate-induced differentiation of human MDA-MB-435 breast cancer cells. Mol. Carcinog., 33, 228-236, 2002.
45. WAF1 is dependent on the activation of ERK during vitamin E-succinate-induced monocytic differentiation. Mol. Cells, 13, 125-129, 2002.
46. Fukuzawa, K., Kogure, K., Morita, M., Hama, S., Manabe, S., and Tokumura, A.: Enhancement of nitric oxide and superoxide generation by α-tocopheryl succinate and its apoptotic and anticancer effects. Biochemistry (Moscow), 69, 64-73, 2004.
47. Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahid, H., Mischak, H., Finkenzeller, G., Marmé, D., and Rapp, U.R.: Protein kinase Ca activates RAF-1 by direct phosphorylation. Nature, 364, 249-252, 1993.
48. Ueda, Y., Hirai, S., Osada, S., Suzuki, A., Mizuno, K., and Ohno, S.: Protein kinase C δ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem., 271, 23512-23519, 1996.
49. Schenk, P.W. and Snaar-Jagalska, B.: Signal perception and transduction: the role of protein kinases. Biochim. Biophys. Acta, 1449, 1-24, 1999.
50. Ferraris, C., Cooklis, M., Polakowska, R.R., and Haake, A.R.: Induction of apoptosis through the PKC pathway in cultured dermal papilla fibroblasts. Exp. Cell Res., 234, 37-46, 1997.
51. Shao, R.-G., Cao, C.-X., and Pommier, Y.: Activation of PKCα downstream from caspases during apoptosis induced by 7-hydroxystaurosporin or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells. J. Biol. Chem., 272, 31321-31325, 1997.
52. Fujii, T., García-Bermejo, M.L., Bernabó, J.L., Caamaño, J., Ohba, M., Kuroki, T., Li, L., Yuspa, S.H., and Kazanietz, M.G.: Involvement of protein kinase C δ (PKCδ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. J. Biol. Chem., 275, 7574-7582, 2000.
53. Zhang, G., Kazanietz, M.G., Blumberg, P.M., and Hurley, J.H.: Crystal structure of the cys2 activator-binding domain of protein kinase C δ in complex with phorbol ester. Cell, 81, 917-924, 1995.
54. Kramer, I.M., Verhoeven, A.J., van der Bend, R.L., Weening, R.S., and Roos, D.: Purified protein kinase C phosphorylates a 47-kDa protein in control neutrophil cytoplasts but not in neutrophil cytoplasts from patients with the autosomal form of chronic granulomatous disease. J. Biol. Chem., 263, 2352-2357, 1998.
55. 2+ and protein kinase C activity. Free Radic. Biol. Med., 26, 580-588, 1999.
56. Gopalakrishna, R., Gundimeda, U., and Chen, Z.: Vitamin E succinate inhibits protein kinase C: Correlation with its unique inhibitory effects on cell growth and transformation, in Nutrients and Cancer, ed. by Prasad, K.N., Human Press, Totawa, NJ, pp. 21-37, 1995.